These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2048577)

  • 21. [Significance of hemoglobin A1C in the management of diabetes in dialysis patients].
    Mácsai E; Rakk E; Miléder M; Fulcz A
    Orv Hetil; 2014 Sep; 155(36):1421-5. PubMed ID: 25176516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycosylated hemoglobin measured by affinity chromatography in diabetic and nondiabetic patients on long-term dialysis therapy.
    Tzamaloukas AH; Hsi KC; Quintana BJ; Merlin TL; Avasthi PS
    West J Med; 1989 Apr; 150(4):415-9. PubMed ID: 2735046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum advanced glycosylation end-products in patients on hemodialysis and CAPD.
    Ateshkadi A; Johnson CA; Founds HW; Zimmerman SW
    Perit Dial Int; 1995; 15(2):129-33. PubMed ID: 7612732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Hemodialysis and Peritoneal Dialysis on Glycometabolism in Patients with End-Stage Diabetic Nephropathy.
    Chen XX; Duan Y; Zhou Y
    Blood Purif; 2021; 50(4-5):506-512. PubMed ID: 33302273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure.
    Makita Z; Bucala R; Rayfield EJ; Friedman EA; Kaufman AM; Korbet SM; Barth RH; Winston JA; Fuh H; Manogue KR
    Lancet; 1994 Jun; 343(8912):1519-22. PubMed ID: 7911868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemoglobin A1c levels in non-diabetic patients with end-stage renal disease (ESRD) receiving hemodialysis.
    Wang X; Peesapati SK; Renedo MF; Moktan S
    J Endocrinol Invest; 2004 Sep; 27(8):733-5. PubMed ID: 15636425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycated hemoglobin in uremic patients as measured by affinity and ion-exchange chromatography.
    Bannon P; Lessard F; Lepage R; Joly JG; Dufresne L
    Clin Chem; 1984 Mar; 30(3):485-6. PubMed ID: 6697506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of adiponectin with cardiovascular events in diabetic and non-diabetic hemodialysis patients.
    Elokely A; Shoukry A; Ghonemy TA; Atia M; Amr G
    Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):736-42. PubMed ID: 22805386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients.
    Hoshino J; Larkina M; Karaboyas A; Bieber BA; Ubara Y; Takaichi K; Akizawa T; Akiba T; Fukuhara S; Pisoni RL; Saito A; Robinson BM
    Kidney Int; 2017 Aug; 92(2):497-503. PubMed ID: 28396123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determination of the metabolic condition in diabetics with renal insufficiency by means of the fructosamine test].
    Wagner R; Löwenstein I; Gieshoff B; Graben N; Olbricht T; Windeck R; Benker G; Reinwein D
    Dtsch Med Wochenschr; 1987 Jan; 112(5):175-7. PubMed ID: 3803236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.
    Drechsler C; Kalim S; Wenger JB; Suntharalingam P; Hod T; Thadhani RI; Karumanchi SA; Wanner C; Berg AH
    Kidney Int; 2015 Jun; 87(6):1201-8. PubMed ID: 25671766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term glycemic control measurements in diabetic patients receiving hemodialysis.
    Joy MS; Cefalu WT; Hogan SL; Nachman PH
    Am J Kidney Dis; 2002 Feb; 39(2):297-307. PubMed ID: 11840370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing glycemic control in patients with diabetes and end-stage renal failure.
    Ansari A; Thomas S; Goldsmith D
    Am J Kidney Dis; 2003 Mar; 41(3):523-31. PubMed ID: 12612974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemoglobin A1c in hemodialysis patients: should one size fit all?
    Ix JH
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1539-41. PubMed ID: 20671219
    [No Abstract]   [Full Text] [Related]  

  • 35. Deranged platelet calcium homeostasis in diabetic patients with end-stage renal failure. A possible link to increased cardiovascular mortality?
    Vicari AM; Taglietti MV; Pellegatta F; Spotti D; Melandri M; Galli L; Ronchi P; Folli F
    Diabetes Care; 1996 Oct; 19(10):1062-6. PubMed ID: 8886550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The value of fructosamine in hemodialysis patients].
    Küenburg E; Brunnbauer M; Watzinger U; Winter F; Müller MM; Graf H; Prager R
    Wien Klin Wochenschr Suppl; 1990; 180():11-3; discussion 32-3. PubMed ID: 2321384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minor hemoglobin components in diabetic and uremic patients.
    Lantz B; Ochoa C; Wajcman H; Fermand JP; Labie D; Assan R
    Horm Metab Res; 1981 Dec; 13(12):660-4. PubMed ID: 7033090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy.
    Jin YP; Su XF; Yin GP; Xu XH; Lou JZ; Chen JJ; Zhou Y; Lan J; Jiang B; Li Z; Lee KO; Ye L; Ma JH
    J Diabetes Complications; 2015 Apr; 29(3):395-9. PubMed ID: 25681043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA).
    Chujo K; Shima K; Tada H; Oohashi T; Minakuchi J; Kawashima S
    J Med Invest; 2006 Aug; 53(3-4):223-8. PubMed ID: 16953058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.